Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study

By Hassanein Mohamed   Hanif Wasim   Malik Waqar   Kamal Ali   Geransar Parnia   Lister Nicola   Andrews Chris   Barnett Anthony  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1367-1374

Informa Healthcare

Access to resources Recommend Favorite

Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice

By Vähätalo Markku   Rönnemaa Tapani   Viikari Jorma  

Scandinavian Journal of Primary Health Care, Vol. 25, Iss. 3, 2007-01 ,pp. : 147-153

Informa Healthcare

Access to resources Recommend Favorite

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

By Hanif W.  

Current Medical Research and Opinion, Vol. 29, Iss. 7, 2013-07 ,pp. : 807-811

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Effect of Pentoxifylline and Captopril on Proteinuria in Patients with Type 2 Diabetes mellitus

By  

Nephron Clin Pract, Vol. 99, Iss. 3, 2005-01 ,pp. : c73-c77

Karger

Access to resources Recommend Favorite

Lipid lowering therapy in type 2 diabetes

By Föger Bernhard  

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 289-296

Springer Publishing Company

Access to resources Recommend Favorite